Dược phẩm

DHG

Dược Hậu Giang

100
+0.10%
Mkt Cap 1.3T
9.8
Strong Sell
Sentiment
+1.00
Impact
1.00
Momentum
+0.04
Fundamentals
+0.00
Volume
0.71
已分析文章
4
主要情绪
Positive
Positive 2
Negative 1
Neutral 1
Apr 21, 2026

DHG Pharmaceutical faces potential loss of its public company status as retail shareholder ownership falls below the 10% minimum required by securities law, with major shareholders Taisho (51.01%) and SCIC (43.31%) holding most shares.

regulation change ↗ 外部来源
7 Negative
Apr 20, 2026

VNDirect (VND) posted Q1 2026 pre-tax profit of VND 681 billion, a 43% year-on-year increase, as part of a broader earnings release wave. TP Securities (ORS) led with a 1,961% surge to VND 42 billion, while ACBS grew 67% to VND 303 billion, highlighting divergent performance in Vietnam's securities sector amid mixed market conditions.

earnings beat
10 Positive
Apr 10, 2026

On April 10th, the Vietnamese stock market maintained its positive momentum with VN-Index increasing over 17 points, led by strong performance in the energy, finance, and real estate sectors. Foreign investors were net buyers, focusing on TCB and HPG, while the information technology and some healthcare stocks saw declines.

↗ 外部来源
4 Positive
Apr 10, 2026

The Ministry of Health has issued a directive to ensure a stable, timely, and reasonably priced supply of essential drugs, urging provinces, hospitals, and pharmaceutical companies to prevent shortages, hoarding, and unreasonable price increases while prioritizing domestic production.

↗ 外部来源
7 Neutral

所有信息仅供参考,不构成投资建议。过往表现不代表未来收益。数据来源于越南公开市场信息。

最后更新: 2026-04-21T17:22:20Z.